期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 20, 期 9, 页码 2864-2867出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2010.03.042
关键词
A(2A) antagonists; A(1) antagonists; Adenosine antagonists; Parkinson's disease; Catalepsy; Dopamine
A novel series of arylindenopyrimidines were identified as A(2A) and A(1) receptor antagonists. The series was optimized for in vitro activity by substituting the 8- and 9-positions with methylene amine substituents. The compounds show excellent activity in mouse models of Parkinson's disease when dosed orally. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据